Avecho Biotechnology Limited
AVEFFOTCHealthcare● Active
$0.00
$-0.00(-20.00%)
Market Cap$10681236
P/E Ratio—
52W High$0.0045
52W Low$0.003
Avecho Biotechnology Limited（AVEFF）· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · AVEFF · 截至 2026-06-09
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $1.24M | $1.29M | $0.47M | $1.21M | $0.79M |
| Cost of Revenue | $0.49M | $0.46M | $0.52M | $0.34M | $0.29M |
| Gross Profit | $0.75M | $0.83M | ($0.04M) | $0.87M | $0.51M |
| Gross Margin %(computed) | 60.70% | 64.39% | -9.25% | 72.14% | 64.00% |
| Operating Expenses | |||||
| R&D Expenses | $4.31M | $0.00M | $1.47M | $1.59M | $1.55M |
| G&A Expenses | $0.00M | $1.99M | $3.08M | $1.49M | $2.83M |
| Total Operating Expenses | $6.75M | $5.63M | $4.72M | $3.86M | $5.06M |
| Operating Income | ($6.00M) | ($4.80M) | ($4.59M) | ($3.06M) | ($4.55M) |
| Operating Margin %(computed) | -485.09% | -370.71% | -969.06% | -254.06% | -573.46% |
| Interest Income | $0.01M | $0.06M | $0.04M | $0.00M | $0.00M |
| Interest Expense | $0.46M | $0.06M | $0.02M | $0.01M | $0.01M |
| Income Before Tax | ($6.41M) | ($3.12M) | ($3.44M) | ($2.34M) | ($3.42M) |
| Income Tax Expense | ($2.00M) | $0.00M | $0.00M | $0.00M | $0.00M |
| Net Income | ($4.41M) | ($3.12M) | ($3.44M) | ($2.34M) | ($3.42M) |
| Net Margin %(computed) | -356.82% | -241.27% | -725.79% | -194.20% | -430.44% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $0.00 | $-0.00 | $-0.00 | $-0.00 | $-0.00 |
| Wtd Avg Shares | 3266.77M | 3107.50M | 2268.08M | 1803.23M | 1802.27M |
| EBITDA | ($5.86M) | ($2.92M) | ($3.24M) | ($2.11M) | ($2.98M) |
| EBITDA Margin %(computed) | -474.02% | -225.66% | -684.83% | -174.63% | -375.25% |
数据来源：Financial Modeling Prep · 最后更新：2026-06-09 · AUD · M
深入了解Avecho Biotechnology Limited
关于Avecho Biotechnology Limited（AVEFF）损益表
Avecho Biotechnology Limited（AVEFF）损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年，AVEFF实现营收$0.00B，毛利润$0.00B（毛利率60.70%），净利润($0.00B)（净利率-356.82%）。
常见问题
AVEFF · 4 问Avecho Biotechnology Limited（AVEFF）2025财年营收为$0.00B，同比down4.4%。
AVEFF revenueAVEFF salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09